AtriCure | ATRC - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Abbott USD 11.66B 1.2B 2026-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 150.1M 6.16M 2026-09
Baxter International USD 6.5B 3.82B 2026-09
Becton, Dickinson and Co. USD 4.16B 20.25B 2026-09
Boston Scientific USD 4.13B 72M 2026-09
Cooper Companies USD 844.2M 268.3M 2026-06
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 10.86B 9.64B 2026-09
Globus Medical USD 585.49M 250.09M 2026-09
Inogen USD 49.14M 665K 2024-09
Insulet USD 652.2M 19.8M 2026-09
Integra LifeSciences USD 368.53M 674.84M 2026-09
Intuitive Surgical USD 2B 86.5M 2026-09
J&J USD 18.93B 1.09B 2026-09
Medtronic USD 7.92B 203M 2026-06
Merit Medical Systems USD 358.44M 20.72M 2026-06
ResMed USD 1.01B 83.57M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 286.06M 17.71M 2026-09
Teleflex USD 3.49B 589.18M 2026-09
Zimmer Biomet Holdings USD 1.72B 110.9M 2026-09